LUIS ALEJANDRO ACABA-BERROCAL
Allopathic & Osteopathic Physicians|Ophthalmology PHILADELPHIA, PA NPI 1336768852
Browse related groups: Allopathic & Osteopathic Physicians|Ophthalmology PA Genentech USA, Inc. All categories
General Payments — all program years on this page
$1,933.19
- Category: General Payments
- Program years: PY2020–2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $684.58 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $684.58 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Genentech USA, Inc. | $289.95 | 3 |
| Bausch & Lomb Americas Inc. | $139.49 | 1 |
| Astellas Pharma US Inc | $107.02 | 1 |
| Alimera Sciences, Inc. | $81.00 | 1 |
| Genentech, Inc. | $67.12 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1092839390 | Alimera Sciences, Inc. | $81.00 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133056424 | Genentech USA, Inc. | $14.91 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133056428 | Genentech USA, Inc. | $123.02 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133056432 | Genentech USA, Inc. | $152.02 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133056436 | Genentech, Inc. | $67.12 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139453876 | Astellas Pharma US Inc | $107.02 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1140398582 | Bausch & Lomb Americas Inc. | $139.49 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.